Skip to content

Lumason

DRUG17 trials

Sponsors

Bracco Diagnostics, Inc, Children's Hospital of Philadelphia, David Mooney, University of California, Los Angeles, Boston Children's Hospital

Conditions

Abdominal InjuryAlzheimer Disease, Early OnsetAtypical Teratoid/Rhabdoid Tumor (ATRT) of the CNSBrain TumorBrain Tumor RecurrentBreast CancerContrast Enhanced UltrasoundCoronary Artery Disease

Early Phase 1

Phase 1

Contrast-Enhanced Ultrasound in the Evaluation of Abdominal Injuries in Children
TerminatedNCT03147690
David MooneyAbdominal Injury
Start: 2017-11-01End: 2019-10-07Updated: 2021-06-11
Radiation-Free Technique for Evaluating Renal Scarring (RAFTERS)
NCT03653702
Boston Children's HospitalVesico-Ureteral Reflux
Start: 2023-10-01End: 2024-06-30Target: 70Updated: 2023-08-31
Contrast Ultrasound for Pediatric Trauma - Comparative Evaluation (CAPTURE Study)
CompletedNCT04718441
David MooneyAbdominal Injury
Start: 2021-05-10End: 2025-07-30Updated: 2025-10-03
Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema
CompletedNCT05613946
Mayo ClinicLymphedema Arm
Start: 2022-12-15End: 2024-06-30Updated: 2024-08-21
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)
RecruitingNCT06329570
NaviFUS CorporationBrain Tumor, Glioblastoma, Glioblastoma Multiforme +3
Start: 2024-10-22End: 2028-03-31Target: 10Updated: 2026-04-09
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
Not yet recruitingNCT06600880
Columbia UniversityAlzheimer Disease, Early Onset
Start: 2027-08-01End: 2028-12-01Target: 6Updated: 2026-05-13
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Not yet recruitingNCT07664176
Children's National Research InstituteAtypical Teratoid/Rhabdoid Tumor (ATRT) of the CNS, Brain Tumor Recurrent, Diffuse Midline Glioma or Diffuse Intrinsic Pontine Glioma +3
Start: 2026-06-01End: 2030-12-01Target: 30Updated: 2026-06-24

Phase 2

Phase 3

Phase 4

Unknown Phase

Related Papers